Opportunity Information: Apply for PA 10 086
Apply for PA 10 086
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.701 Trans NIH Recovery Act Research Support.
- This funding opportunity was created on Mar 17, 2010 and posted on Mar 17, 2010.
- Applicants must submit their applications by May 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) State governments Special district governments For profit organizations other than small businesses Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) City or township governments Public housing authorities/Indian housing authorities Independent school districts Public and State controlled institutions of higher education Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA) funding opportunity PA 10 086, titled "The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R21)," supports exploratory research focused on how alcohol harms the body at the level of cellular organelles. The central idea is that excessive alcohol use can injure multiple organs, including the liver, heart, pancreas, brain, and lungs, but many of the underlying biological mechanisms remain incomplete or poorly defined. This FOA is built around the view that organelles (the specialized structures inside cells that carry out essential functions) are not just passive bystanders in alcohol related damage. Instead, they may be primary sites where alcohol disrupts normal cellular function, leading to inflammation, cell stress, impaired metabolism, and ultimately tissue injury. By encouraging mechanistic studies that look directly at organelle structure and function in the context of alcohol exposure, the FOA aims to move the field toward clearer causal explanations and more actionable clinical insights.
The opportunity highlights three major scientific goals. First, it seeks projects that clarify how acute or chronic alcohol consumption changes organelle structure and function, and how those organelle level changes contribute to tissue injury. In practical terms, this could include studying how alcohol alters energy production, cellular stress responses, intracellular trafficking, membrane integrity, or organelle communication, and then linking those changes to measurable injury outcomes in relevant tissues. Second, the FOA encourages research into why individuals differ in their biological responses to alcohol, specifically by examining variations in organelle associated proteins and how those proteins are regulated. This includes attention to cellular signaling pathways that control organelle behavior, quality control, and adaptive or maladaptive responses to alcohol related stress. Third, the FOA prioritizes translational outputs: identifying potential biomarkers that could be used for prognosis or diagnosis of alcohol induced tissue injury, and pointing to new molecular targets that might support therapeutic interventions. The underlying expectation is that by understanding where and how organelles fail under alcohol exposure, researchers may uncover indicators that appear early in disease progression or reveal leverage points for treatment.
A notable emphasis of the announcement is innovation in both experimental design and technology. Applicants are encouraged to use emerging and data rich approaches such as genomics, proteomics, metabolomics, and bioinformatics, alongside advanced microscopy and imaging methods capable of visualizing organelle function in intact cells and tissues. The FOA is essentially inviting applicants to go beyond traditional, single pathway explanations and instead use modern tools to capture complex organelle centered mechanisms, interactions, and system level responses that might explain how alcohol triggers injury across different organ systems. This also reflects an interest in generating discoveries that are both mechanistically rigorous and clinically informative, rather than purely descriptive findings.
In terms of funding structure, this announcement uses the NIH Exploratory/Developmental Research Grant (R21) mechanism, which is typically suited for early stage, high impact ideas that may still require preliminary proof of concept. The FOA is described as running in parallel with another announcement of the same scientific scope that uses the R01 mechanism (PA 10 085), which generally supports larger, more mature projects. The award ceiling listed for this R21 opportunity is $200,000, and cost sharing or matching is not required. Specific award numbers and total funds are not guaranteed; awards depend on the availability of funds and the volume and quality of applications received, and project size and duration may vary depending on what is proposed.
Eligibility is broad and includes many organization types: public and private institutions of higher education; nonprofits (including those with and without 501(c)(3) status, with exceptions as stated); for profit organizations (including small businesses and other for profits); state, local, and tribal governments; public housing authorities; independent school districts; and various special district and county or city entities. The FOA also explicitly includes additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith based or community based organizations, eligible federal agencies, U.S. territories or possessions, and non U.S. entities (foreign organizations). This broad eligibility is consistent with NIH efforts to encourage diverse participation and leverage specialized expertise across sectors and regions.
Key administrative details from the source include: the funding instrument is a grant, the activity category is health, and the CFDA number listed is 93.701. The FOA was posted and created on March 17, 2010, with an original and current closing date of May 7, 2013, and an archive date of June 7, 2013. The sponsoring agency is the National Institutes of Health, with NIAAA as the institute leading the scientific focus. Overall, the opportunity is designed to catalyze organelle centered, technology enabled research that can explain how alcohol damages tissues and can ultimately improve diagnosis, prognosis, and treatment strategies for alcohol related disease.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is NIH NIAAA Funding Opportunity PA 10 086, titled "The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R21)."
Which agency and institute sponsor this opportunity?
The sponsoring agency is the National Institutes of Health (NIH), with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) leading the scientific focus.
What type of funding instrument is this?
The funding instrument is a grant.
What grant mechanism does this opportunity use?
This opportunity uses the NIH Exploratory/Developmental Research Grant (R21) mechanism.
What is the main research focus of PA 10 086?
It supports exploratory research on how alcohol causes tissue injury by disrupting cellular organelles. The emphasis is on organelles as primary sites where alcohol can impair normal cellular function and trigger downstream effects such as inflammation, cellular stress, impaired metabolism, and tissue damage.
Which organs or tissues are highlighted as affected by alcohol-induced injury?
The opportunity highlights that excessive alcohol use can injure multiple organs, including the liver, heart, pancreas, brain, and lungs.
Why does this opportunity focus on cellular organelles specifically?
The premise is that organelles are not passive bystanders in alcohol-related damage. Instead, alcohol may directly disrupt organelle structure and function, contributing to measurable injury outcomes in tissues and helping explain biological mechanisms that are currently incomplete or poorly defined.
What are the major scientific goals emphasized in the announcement?
Three major goals are emphasized: (1) clarifying how acute or chronic alcohol exposure changes organelle structure and function and how those changes contribute to tissue injury; (2) understanding why individuals differ in biological responses to alcohol by examining variations in organelle-associated proteins and their regulation; and (3) producing translational outputs such as potential biomarkers and new molecular targets for therapeutic intervention.
What kinds of mechanistic questions or processes are considered relevant under this FOA?
Examples mentioned include studying alcohol-related effects on energy production, cellular stress responses, intracellular trafficking, membrane integrity, and organelle communication, and linking those organelle-level changes to measurable tissue injury outcomes.
Does the FOA address differences in how individuals respond to alcohol?
Yes. It encourages research into individual differences by focusing on variations in organelle-associated proteins, how those proteins are regulated, and the signaling pathways that control organelle behavior, quality control, and adaptive or maladaptive responses to alcohol-related stress.
What translational outcomes does the FOA prioritize?
The FOA prioritizes identifying potential biomarkers that could support prognosis or diagnosis of alcohol-induced tissue injury, and identifying new molecular targets that may support therapeutic interventions.
Is innovation in methods and technology encouraged?
Yes. The FOA emphasizes innovation in experimental design and technology, encouraging emerging and data-rich approaches and advanced imaging to study organelle structure and function in intact cells and tissues.
Which advanced approaches are specifically encouraged?
The announcement highlights genomics, proteomics, metabolomics, and bioinformatics, as well as advanced microscopy and imaging methods capable of visualizing organelle function in intact cells and tissues.
How does this R21 opportunity relate to the R01 opportunity mentioned?
This R21 announcement (PA 10 086) is described as running in parallel with another announcement of the same scientific scope that uses the R01 mechanism (PA 10 085), which generally supports larger and more mature projects.
What is the award ceiling for this R21 opportunity?
The award ceiling listed is $200,000.
Is cost sharing or matching required?
No. Cost sharing or matching is not required.
Are awards guaranteed under this opportunity?
No. The announcement indicates that specific award numbers and total funds are not guaranteed. Awards depend on the availability of funds and the volume and quality of applications received.
Can project size and duration vary?
Yes. The opportunity notes that project size and duration may vary depending on what is proposed.
Who is eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofit organizations (including those with and without 501(c)(3) status, with exceptions as stated); for-profit organizations (including small businesses and other for-profits); and various government entities such as state, local, and tribal governments.
Are specific education-focused or community-focused institutions included in eligibility?
Yes. The FOA explicitly includes Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities, as well as faith-based or community-based organizations.
Are U.S. territories, possessions, federal agencies, or non-U.S. entities eligible?
Yes. The FOA includes eligible federal agencies, U.S. territories or possessions, and non-U.S. entities (foreign organizations).
What is the activity category for this opportunity?
The activity category listed is health.
What CFDA number is associated with this opportunity?
The CFDA number listed is 93.701.
When was the opportunity posted, and what are the key dates provided?
The FOA was posted/created on March 17, 2010. The original and current closing date listed is May 7, 2013. The archive date listed is June 7, 2013.
What is the overall intent of this FOA in the broader research landscape?
The intent is to catalyze organelle-centered, technology-enabled research that provides clearer causal explanations for alcohol-induced tissue injury and generates clinically informative outputs that could improve diagnosis, prognosis, and treatment strategies for alcohol-related disease.
Browse more opportunities from the same category: Health
Next opportunity: Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21)
Previous opportunity: The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 10 086
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 10 086) also looked into and applied for these:
| Funding Opportunity |
|---|
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R21) Apply for PA 10 094 Funding Number: PA 10 094 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R01) Apply for PA 10 093 Funding Number: PA 10 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R01) Apply for PA 10 100 Funding Number: PA 10 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R21) Apply for PA 10 102 Funding Number: PA 10 102 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R03) Apply for PA 10 101 Funding Number: PA 10 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analyses of Social and Behavioral Datasets in Aging (R03) Apply for PA 10 139 Funding Number: PA 10 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technical Assistance to Behavior Change Communication (BCC) on Comprehensive Peer Education Program and the National AIDS Resource Center (NARC) Programs under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10116 Funding Number: CDC RFA PS10 10116 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Ancillary Studies in Clinical Trials (R01) Apply for RFA HL 10 024 Funding Number: RFA HL 10 024 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Hepatitis C Treatment Expansion Initiative Evaluation and Technical Assistance Center Apply for HRSA 10 216 Funding Number: HRSA 10 216 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Division of Diabetes Translation Earmarks 2010 Apply for CDC RFA DP10 1004E Funding Number: CDC RFA DP10 1004E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Transforming Biomedicine at the Interface of the Life and Physical Sciences (R01) Apply for PAR 10 141 Funding Number: PAR 10 141 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Excellence for Research on CAM (CERC) for Pain (P01) Apply for RFA AT 10 002 Funding Number: RFA AT 10 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods for Prevention Packages Program (MP3 II) (R01) Apply for RFA AI 10 005 Funding Number: RFA AI 10 005 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) In the Epilepsies (R01) Apply for RFA NS 11 003 Funding Number: RFA NS 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| New Biomedical Frontiers at the Interface of the Life and Physical Sciences (R01) Apply for PAR 10 142 Funding Number: PAR 10 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Logistics And Technical Support For CDC Health Workforce And Systems Capacity Development In Multiple Countries Apply for CDC RFA GH11 1102 Funding Number: CDC RFA GH11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Chronic Disease Prevention and Health Promotion Projects Apply for RFA DP10 009E Funding Number: RFA DP10 009E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Adult and Community Health Apply for CDC RFA DP10 1020E Funding Number: CDC RFA DP10 1020E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Heart Disease and Stroke Prevention Projects Apply for CDC RFA DP10 1023E Funding Number: CDC RFA DP10 1023E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Texas Tech University Health Science Center Apply for RFA IP10 011E Funding Number: RFA IP10 011E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 10 086", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
